Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer
2021 · Cancers · 15 citations
https://doi.org/10.3390/cancers13143504
C
Carla Corvaja
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
785
Citations
15
h-index
19
i10-index
Carla Corvaja is an academic researcher. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Colorectal Cancer Treatments and Studies. The author has an h-index of 15, co-authored 57 publications.
ORCID: 0000-0002-2535-7538Papers by this author
worksHER2 in Non-Small Cell Lung Cancer (NSCLC): Evolution of the Therapeutic Landscape and Emerging Drugs—A Long Way to the Top
2025 · Molecules · 13 citations
https://doi.org/10.3390/molecules30122645
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients
2018 · Annals of Oncology · 1 citations
https://doi.org/10.1093/annonc/mdy272.292
Deciding on the best pharmacotherapy for advanced triple-negative breast cancer: expert guidance
2022 · Expert Opinion on Pharmacotherapy · 1 citations
https://doi.org/10.1080/14656566.2022.2139176
The SENECA study: Prognostic role of serum biomarkers in elderly metastatic colorectal cancer patients
2018 · Annals of Oncology · 0 citations
https://doi.org/10.1093/annonc/mdy281.139
Determinants of oncologist’s choice in offering drug holidays during first line therapy for patients with metastatic colorectal cancer
2018 · Annals of Oncology · 0 citations
https://doi.org/10.1093/annonc/mdy281.140
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat